Uterine cancer affects 28 in 100,000 women annually. Learn the 5 critical warning signs that could save your life and why ...

I welcomed my first child into the world. About fifteen hours before I went into labor, I was diagnosed with breast cancer,” ...

The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic ...

Shay Wahl would be the first to tell you that patience isn’t her strong suit. But she’s working on it through her hobbies.

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and ...

Antibody-drug conjugates and their development remains a central theme in ongoing research within the realm of ovarian cancer ...

Barriers contributing to underreporting of fatigue also include belief that symptom is sign disease is progressing and attempt to be a “good patient.” ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Results from a new Phase 3 trial published in the journal npj Precision Oncology found that a cancer stem cell test can ...